Inhibitory effect of Kyungohkgo in the development of 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice

Archives of Pharmacal Research - Tập 34 - Trang 317-321 - 2011
Lee-Rang Im1, Ji-Young Ahn1, Jun-Ho Kim1, Mingjie Xin1, Se-Uk Kwon1, Yun-Kyung Kim1, Dae-Ki Kim2, Young-Mi Lee1,3
1Department of Oriental Pharmacy, College of Pharmacy Wonkwang University and Wonkwang-Oriental Medicines Research Institute, Iksan, Korea
2Department of Immunology, Medical School and Institute of Medical Sciences, Chonbuk National University, Jeonju, Korea
3Department of Oriental Pharmacy, College of Pharmacy, Wonkwang University, Iksan, Korea

Tóm tắt

Kyungohkgo (KOG) is one of the most important formulas in traditional oriental medicine. We investigated the remedial effect of KOG on the development of atopic dermatitis (AD) in female NC/Nga mice. AD-like lesion was induced by the application of 2,4-Dinitrochlorobenzene on to the back skin repeatedly; KOG was administered orally (12.5 and 25.0 mg/kg) and topically (0.5 and 1.0 mg/mouse) to NC/Nga mice once a day for all through the period of this experiment and every mouse body weight was periodically taken. The effects of KOG on 2,4-Dinitrochlorobenzene-treated NC/Nga mice were determined by measuring AD-like skin lesions, the infiltration of mast cells and serum immunoglobulin E concentration. After the KOG applications are over, the KOG groups had less skin lesions than the atopy one, their immunoglobulin E levels were significantly downregulated and the infiltration of mast cells in the dorsal skin were reduced. Our results suggest that KOG may be effective in alleviating the development of AD. The inhibition of AD in NC/Nga mice may be influenced by the prevention of mast cell activation.

Tài liệu tham khảo

Al-Waili, N. S., Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complement. Ther. Med, 11, 226–234 (2003). Arellano, F. M., Wentworth, C. E., Arana, A., Fernandez, C., and Paul, C. F., Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J. Invest. Dermatol, 127, 808–816 (2007). Budde, I. K., Heer, P. G., Natter, S., Natter, S., van der Zee, J. D., Valenta, R., and Aalberse, R. C., Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors. Immunology, 107, 243–251 (2002). Choi, J. H., Kim, H. M., Song, Y. S., Park, S. G., Kim, J. J., and Lee, C. K., Physiological effects of the cosmetic product containing of saccharomyces fermented modified kyungohkgo extract on human skin. Kor. J. Herbology, 22, 227–232 (2007a). Choi, J. H., Kim, H. M., Song, Y. S., Park, S. G., Kim, J. J., and Lee, C. K., Anti-aging effects saccharomyces fermented modified kyungohkgo extract on skin. Kor. J. Herbology, 22, 219–225 (2007b). Ellis, C. N., Drake, L. A., Prendergast, M. M., Abramovits, W., Boguniewicz, M., Daniel, C. R., Sebwohl, M., Stevens, S. R., Whitaker-Worth, D. L., Cheng, J. W., and Tong, K. B., Cost of atopic dermatitis and eczema in the United States. J. Am. Acad. Dermatol, 46, 361–370 (2002). Fuchs, S. M., Heinemann, C., Schliemann-Willers, S., Hartl, G, Fluhr J. W., and Elsner, P., Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphateinduced irritant contact dermatitis. Skin Res. Technol., 12, 223–227 (2006). Gao, X. K., Fuseda, K., Shibata, T., Tanaka, H., Inagaki, N., and Nagai, H., Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid. Based Complement Alternat. Med, 2, 191–199 (2005). Hanifin, J. M., Cooper, K. D., Ho, V. C., Kang, S., Krafchik, B. R., Margolis, D. J., Schachner, L. A., Sidbury, R., Whimore, S. E., Sieck, C. K., and Van Voorhees, A. S., Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology(AAD)/American Academy of Dermatology Association “Administrative Regulations for Evidence-Based Clinical Practice Guidelines”. J. Am. Acad. Dermatol, 50, 391–404 (2004). Hankin, C. S., Cox, L., Lang, D., Bronstone, A., Rass, P., Seatherman, B., and Wang, Z., Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann. Allergy Asthma Immunol, 104, 79–85 (2010). Iijima, K., Sun, S., Cyong, J. C., and Jyonouchi, H., Juzentaiho-to, a Japanese herbal medicine, modulates type 1 and type 2 T cell responses in old BALB/c mice. Am. J. Clin. Med, 27, 191–203 (1999). Lee, E. S., Seo, B. I., Lee, J. W., and Bae, J. S., Effects of kyungohkgo and prescription of modified kyungohkgo on lung cancer. Kor. J. Herbology, 17, 101–109 (2002a). Lee, E. S., Seo, B. I., Lee, J. W., and Bae, J. S., The immunological activities of kyungohkgo and prescription of modified kyungohkgo. Kor. J. Herbology, 17, 95–100 (2002b). Lee, S. Y., Shin, Y. J., Park, J. H., Kim, S. M., and Park, C. S., An Analysis of the gyungokgo’s ingredients and a comparison study on anti-oxidation effects according to the kinds of extract. Kor. J. Herbology, 23, 123–136 (2008). Leung, D. Y. and Bieber, T., Atopic dermatitis. Lancet, 361, 151–160 (2003). Matsumoto, M., Ra, C., Kawamoto, K., Sato, H., Itakura, A., Sawada, J., Ushio, H., Suto, H., Mitsuishi, K., Hikasa, Y., and Matsuda, H., IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol., 162, 1056–1063 (1999). Norris, D. A., Mechanisms of action of topical therapies and the rationale for combination therapy. J. Am. Acad. Dermatol, 53, 17–25 (2005). Piloto Valdes, L., Gomez Echevarria, A. H., Valdes Sanchez, A. F., Ochoa, C., Chong Lopez, A., Mier Naranjo, G., Atopic dermatitis. Findings of skin biopsies. Allergol. Immunopathol., 18, 321–324 (1990). Sasakawa, T., Higashi, Y., Sakuma, S., Hirayama, Y., Sasakawa, Y., Goto, T., Matsumoto, M., and Matsuda, H., Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int. Arch. Allergy Immunol, 126, 239–247 (2001). Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C., and Kim, D. H., Effect of ginsenoside Rb1 and compound K in chronic oxazoloneinduced mouse dermatitis. Int. Immunopharmacol., 5, 1183–1191 (2005). Sicherer, S. H. and Leung, D. Y., Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects. J. Allergy Clin. Immunol, 121, 1351–1358 (2008). Suto, H., Matsuda, H., Mitsuishi, K., Hira, K., Uchida, T., Unno, T., Ogawa, H., and Ra, C., NC/Nga mice: A mouse model for atopic dermatitis. Int. Arch. Allergy Immunol., 120, 70–75 (1999). Terasawa, K., Evidence-based reconstruction of kampo medicine: Part I-Is Kampo CAM. Evid. Based Complement Alternat. Med., 1, 11–16 (2004). Van Bever, H. P., Recent advances in the pathogenesis of atopic dermatitis. Eur. J. Pediatr, 151, 870–873 (1992). Volker, S., Dan, B., Andrew, E., and Randall, B., Chinese Herbal Medicine Formulas & Strategies 2nd Edition. Eastland Press, Seattle, pp. 389–391, (2009). Whang, W. K., Oh, I. S., Kim, Y. B., Shin, S. D., and Kim, I. H., The physiological activities of KYUNG OK KO (III)-effects on inflammation, gastric ulcer, analgesic and homothermics. Kor. J. Pharmacogn, 25, 153–159 (1994a). Whang, W. K., Oh, I. S., Lee, S. H., Choi, S. B., and Kim, I. H., The Physiological Activities of Kyung Ok-Ko (II)-Effects on the hyperglycemia, hypertension, anti-fatigue and decrease of body weight. Kor. J. Pharmacogn, 25, 51–58 (1994b).